We are studying an investigational drug, denifanstat, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with noncirrhotic NASH (non-alcoholic steatohepatitis) MASH (metabolic dysfunction-associated steatohepatitis).
At each visit, we will collect your vials and blood, perform an eye-exam, and ask you questions about your health since the last visit. You will be taking a medication orally each day. You may be asked to have a liver biopsy done if you have not had one previously and we'll take scans of your liver to monitor throughout the study.
Information provided upon request
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
A Barritt
Center for Gastrointestinal Biology and Disease
Clinical or Medical
Interventional
Kidneys and Liver
24-2226
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
